Boothbay Fund Management, LLC Cumberland Pharmaceuticals Inc Transaction History
Boothbay Fund Management, LLC
- $5.7 Billion
- Q3 2025
A detailed history of Boothbay Fund Management, LLC transactions in Cumberland Pharmaceuticals Inc stock. As of the latest transaction made, Boothbay Fund Management, LLC holds 168,132 shares of CPIX stock, worth $354,758. This represents 0.01% of its overall portfolio holdings.
Number of Shares
168,132
Previous 180,229
6.71%
Holding current value
$354,758
Previous $603,000
13.93%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding CPIX
# of Institutions
33Shares Held
3.39MCall Options Held
24.7KPut Options Held
21.3K-
Israel Englander Millennium Management LLC | New York, Ny599KShares$1.26 Million0.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX556KShares$1.17 Million0.27% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny515KShares$1.09 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA412KShares$868,8680.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX281KShares$592,6330.0% of portfolio
About CUMBERLAND PHARMACEUTICALS INC
- Ticker CPIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 14,661,900
- Market Cap $30.9M
- Description
- Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, rheumatology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen ...